$1.79 Billion is the total value of HARVARD MANAGEMENT CO INC's 38 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 53.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RPRX | Sell | ROYALTY PHARMA PLC | $467,357,000 | -36.4% | 10,714,284 | -27.1% | 26.11% | -34.5% |
ICE | New | INTERCONTINENTAL EXCHANGE IN | $230,334,000 | – | 2,062,444 | +100.0% | 12.87% | – |
ADBE | New | ADOBE SYSTEMS INCORPORATED | $155,018,000 | – | 326,100 | +100.0% | 8.66% | – |
ABCL | ABCELLERA BIOLOGICS INC | $139,409,000 | -15.6% | 4,105,095 | 0.0% | 7.79% | -13.1% | |
FB | Buy | FACEBOOK INCcl a | $120,667,000 | +8.7% | 409,695 | +0.8% | 6.74% | +11.9% |
PANW | Buy | PALO ALTO NETWORKS INC | $109,790,000 | +84.8% | 340,900 | +103.9% | 6.13% | +90.3% |
SGMS | SCIENTIFIC GAMES CORP | $103,179,000 | -7.2% | 2,678,571 | 0.0% | 5.76% | -4.4% | |
MSFT | Sell | MICROSOFT CORP | $61,723,000 | -66.2% | 261,792 | -68.1% | 3.45% | -65.2% |
CRM | Sell | SALESFORCE COM INC | $34,878,000 | -83.1% | 164,622 | -82.3% | 1.95% | -82.6% |
QQQ | Sell | INVESCO QQQ TRunit ser 1 | $34,448,000 | -2.6% | 107,944 | -4.3% | 1.92% | +0.3% |
PCT | New | PURECYCLE TECHNOLOGIES INC | $32,545,000 | – | 1,276,267 | +100.0% | 1.82% | – |
RVMD | REVOLUTION MEDICINES INC | $30,757,000 | +15.9% | 670,382 | 0.0% | 1.72% | +19.3% | |
IVV | Buy | ISHARES TRcore s&p500 etf | $26,064,000 | +7.4% | 65,516 | +1.3% | 1.46% | +10.6% |
PRAX | Sell | PRAXIS PRECISION MEDICINES I | $25,504,000 | -41.5% | 778,517 | -1.8% | 1.42% | -39.7% |
PLRX | PLIANT THERAPEUTICS INC | $22,118,000 | +73.1% | 562,379 | 0.0% | 1.24% | +78.4% | |
RLAY | RELAY THERAPEUTICS INC | $18,707,000 | -16.8% | 541,124 | 0.0% | 1.04% | -14.3% | |
U | New | UNITY SOFTWARE INC | $18,697,000 | – | 186,396 | +100.0% | 1.04% | – |
TXG | New | 10X GENOMICS INC | $16,195,000 | – | 89,476 | +100.0% | 0.90% | – |
SANA | New | SANA BIOTECHNOLOGY INC | $15,689,000 | – | 468,749 | +100.0% | 0.88% | – |
KNTE | KINNATE BIOPHARMA INC | $15,518,000 | -21.7% | 498,001 | 0.0% | 0.87% | -19.3% | |
GLD | Buy | SPDR GOLD TR | $15,462,000 | -10.3% | 96,662 | +0.0% | 0.86% | -7.6% |
GBIO | Sell | GENERATION BIO CO | $14,581,000 | -1.4% | 512,349 | -1.7% | 0.82% | +1.6% |
RBLX | New | ROBLOX CORPcl a | $12,813,000 | – | 197,642 | +100.0% | 0.72% | – |
NRIX | NURIX THERAPEUTICS INC | $9,786,000 | -5.4% | 314,762 | 0.0% | 0.55% | -2.5% | |
VEA | Buy | VANGUARD TAX-MANAGED INTL FDftse dev mkt etf | $8,640,000 | +5.2% | 175,937 | +1.1% | 0.48% | +8.3% |
PDD | New | PINDUODUO INCsponsored ads | $5,689,000 | – | 42,490 | +100.0% | 0.32% | – |
IJR | Buy | ISHARES TRcore s&p scp etf | $5,459,000 | +19.5% | 50,304 | +1.2% | 0.30% | +23.0% |
NCNA | Sell | NUCANA PLCsponsored adr | $4,952,000 | -34.3% | 992,405 | -40.9% | 0.28% | -32.3% |
FULC | FULCRUM THERAPEUTICS INC | $4,838,000 | +0.6% | 410,714 | 0.0% | 0.27% | +3.4% | |
IJH | Sell | ISHARES TRcore s&p mcp etf | $4,198,000 | +12.4% | 16,129 | -0.8% | 0.24% | +15.8% |
VWO | Buy | VANGUARD INTL EQUITY INDEX Fftse emr mkt etf | $4,190,000 | +4.0% | 80,501 | +0.2% | 0.23% | +7.3% |
FSII | New | FS DEVELOPMENT CORP II | $3,984,000 | – | 400,000 | +100.0% | 0.22% | – |
MGTA | MAGENTA THERAPEUTICS INC | $3,938,000 | +51.0% | 332,610 | 0.0% | 0.22% | +56.0% | |
DBTX | New | DECIBEL THERAPEUTICS INC | $3,735,000 | – | 328,798 | +100.0% | 0.21% | – |
GMTX | New | GEMINI THERAPEUTICS INC | $3,388,000 | – | 250,000 | +100.0% | 0.19% | – |
MCRB | SERES THERAPEUTICS INC | $2,715,000 | -15.9% | 131,847 | 0.0% | 0.15% | -13.1% | |
DYN | DYNE THERAPEUTICS INC | $1,666,000 | -26.0% | 107,252 | 0.0% | 0.09% | -23.8% | |
DADA | New | DADA NEXUS LTDads | $1,354,000 | – | 49,887 | +100.0% | 0.08% | – |
PGNY | Exit | PROGYNY INC | $0 | – | -3,755 | -100.0% | -0.01% | – |
TWLO | Exit | TWILIO INCcl a | $0 | – | -2,021 | -100.0% | -0.04% | – |
CG | Exit | CARLYLE GROUP INC | $0 | – | -23,600 | -100.0% | -0.04% | – |
FSDC | Exit | FS DEV CORP | $0 | – | -250,000 | -100.0% | -0.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-07
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 34 | Q3 2021 | 19.4% |
VANGUARD TAX-MANAGED INTL FD | 34 | Q3 2021 | 14.0% |
VANGUARD INTL EQUITY INDEX F | 34 | Q3 2021 | 12.2% |
SPDR GOLD TRUST | 34 | Q3 2021 | 8.7% |
ISHARES TR | 34 | Q3 2021 | 4.9% |
META PLATFORMS INC | 29 | Q3 2023 | 37.6% |
VANGUARD SPECIALIZED PORTFOL | 28 | Q1 2020 | 2.8% |
MAGENTA THERAPEUTICS INC | 21 | Q2 2023 | 1.4% |
ALPHABET INC | 19 | Q3 2023 | 30.4% |
ISHARES TR | 19 | Q3 2021 | 4.4% |
View HARVARD MANAGEMENT CO INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NuCana plc | February 12, 2021 | 1,678,239 | 3.3% |
ADURO BIOTECH, INC. | February 08, 2019 | 640,595 | 0.8% |
Fortress Transportation & Infrastructure Investors LLCSold out | July 08, 2016 | 0 | 0.0% |
Alpha Security Group CORP | February 13, 2009 | 436,300 | 5.8% |
BLOCKBUSTER INC | February 13, 2009 | 5,567,100 | 7.7% |
ChinaGrowth North Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
ChinaGrowth South Acquisition CORPSold out | February 13, 2009 | 0 | 0.0% |
GENEVA ACQUISITION CORPSold out | February 13, 2009 | 0 | 0.0% |
Ideation Acquisition Corp. | February 13, 2009 | 310,200 | 2.5% |
MBF Healthcare Acquisition Corp. | February 13, 2009 | 1,220 | 0.0% |
View HARVARD MANAGEMENT CO INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-12 |
View HARVARD MANAGEMENT CO INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.